Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8090 | 1220 | 29.0 | 66% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1177 | 8930 | GROUP B STREPTOCOCCUS//PROCALCITONIN//NECROTIZING ENTEROCOLITIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LATE ONSET SEPSIS | Author keyword | 22 | 53% | 2% | 30 |
2 | NEONATAL SEPSIS | Author keyword | 8 | 12% | 5% | 58 |
3 | CLIN NEONATOL INTENS NEONATAL CARE | Address | 5 | 63% | 0% | 5 |
4 | NEONATOL PEDIAT HEMATOL ONCOL | Address | 5 | 50% | 1% | 7 |
5 | NEONATAL SEPTICEMIA | Author keyword | 4 | 36% | 1% | 10 |
6 | BACTERIOLOGICAL PROFILE | Author keyword | 4 | 75% | 0% | 3 |
7 | GRAM NEGATIVE BLOODSTREAM INFECTION | Author keyword | 4 | 75% | 0% | 3 |
8 | EARLY ONSET SEPSIS | Author keyword | 4 | 25% | 1% | 14 |
9 | NEONATAL INFECTIONS | Author keyword | 3 | 18% | 1% | 13 |
10 | NORTON HEALTHCARE INC | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LATE ONSET SEPSIS | 42 | 34% | 8% | 99 |
2 | NEGATIVE STAPHYLOCOCCAL BACTEREMIA | 30 | 51% | 4% | 43 |
3 | RESEARCH NETWORK | 15 | 20% | 6% | 70 |
4 | HEPARIN LOCK SOLUTION | 12 | 86% | 0% | 6 |
5 | ONSET SEPSIS | 8 | 27% | 2% | 25 |
6 | BODY SURFACE CULTURES | 5 | 54% | 1% | 7 |
7 | CENTRAL VASCULAR CATHETER | 4 | 75% | 0% | 3 |
8 | INFANTS LESS THAN 60 DAYS | 4 | 75% | 0% | 3 |
9 | INTRAVENOUS RIFAMPICIN | 4 | 75% | 0% | 3 |
10 | POINT PREVALENCE SURVEY | 3 | 30% | 1% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Community-acquired neonatal and infant sepsis in developing countries: efficacy of WHO's currently recommended antibiotics-systematic review and meta-analysis | 2013 | 23 | 20 | 50% |
Late-onset neonatal sepsis: recent developments | 2015 | 1 | 65 | 37% |
Challenges in the diagnosis and management of neonatal sepsis | 2015 | 1 | 81 | 27% |
Hospital-acquired neonatal infections in developing countries | 2005 | 164 | 93 | 41% |
Neonatal nosocomial infections | 1998 | 66 | 16 | 75% |
Healthcare-associated infections in the hospitalized neonate: a review | 2014 | 3 | 11 | 45% |
Improving antibiotic prescribing in neonatal units: time to act | 2012 | 12 | 28 | 43% |
Managing and preventing outbreaks of Gram-negative infections in UK neonatal units | 2013 | 7 | 17 | 47% |
A ten-year review of neonatal bloodstream infections in a tertiary private hospital in Kenya | 2011 | 6 | 7 | 86% |
Effectiveness of non-pharmacological interventions for the prevention of bloodstream infections in infants admitted to a neonatal intensive care unit: A systematic review | 2013 | 7 | 38 | 45% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN NEONATOL INTENS NEONATAL CARE | 5 | 63% | 0.4% | 5 |
2 | NEONATOL PEDIAT HEMATOL ONCOL | 5 | 50% | 0.6% | 7 |
3 | NORTON HEALTHCARE INC | 2 | 67% | 0.2% | 2 |
4 | QUAL SERV INFECT CONTROL PROGRAM | 1 | 100% | 0.2% | 2 |
5 | UBERLANDIA UNIV HOSP | 1 | 100% | 0.2% | 2 |
6 | MIDWIFERY PROFESSORIAL UNIT | 1 | 30% | 0.2% | 3 |
7 | HOSP UNIV LONDRINA | 1 | 33% | 0.2% | 2 |
8 | BIYOSTAT ANABILIM DALI | 1 | 50% | 0.1% | 1 |
9 | BUR INT HLTH | 1 | 50% | 0.1% | 1 |
10 | C CLIN QUEST | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000186007 | BUNDES INFEKT KRANKHEITEN NICHT UBERTRAGBAR//NEONATAL BACTERIAL INFECTION//PMEU |
2 | 0.0000125463 | CANDIDURIA//FUNGURIA//CONGENITAL CANDIDIASIS |
3 | 0.0000114710 | INFECTION DRUG THERAPY MORTALITY//CORD BLOOD NEUTROPHILS//FK 409 |
4 | 0.0000109152 | CATHETER RELATED BLOODSTREAM INFECTION//CATHETER RELATED INFECTION//CENTRAL VENOUS CATHETER |
5 | 0.0000099217 | STAPHYLOCOCCUS LUGDUNENSIS//COAGULASE NEGATIVE STAPHYLOCOCCI//STAPHYLOCOCCUS SAPROPHYTICUS |
6 | 0.0000098582 | GROUP B STREPTOCOCCUS//STREPTOCOCCUS AGALACTIAE//INTRAPARTUM ANTIBIOTIC PROPHYLAXIS |
7 | 0.0000097817 | SERRATIA MARCESCENS//CYTOTOXIN PRODUCTION//PHARMAZEUT BIOL MIKROBIOL |
8 | 0.0000088739 | PROCALCITONIN//PRESEPSIN//NEUTROPHIL CD64 |
9 | 0.0000082754 | BLOOD CULTURE//BLOOD CULTURES//TIME TO POSITIVITY |
10 | 0.0000081397 | SURGICAL SITE INFECTIONS//AMERICAN JOURNAL OF INFECTION CONTROL//POST DISCHARGE SURVEILLANCE |